(Reuters) – Advisers to the U.S. Food and Drug Administration on Tuesday voted to recommend authorization of Novavax Inc’s COVID-19 vaccine for adults.
(Reporting by Manas Mishra in Bengaluru; Editing by Bill Berkrot)
Novavax COVID vaccine gets backing of U.S. FDA advisers
Jun 7, 2022 | 3:33 PM
